期刊文献+

他克莫司联合小剂量激素治疗儿童激素抵抗型肾病综合征临床观察 被引量:3

下载PDF
导出
摘要 目的观察他克莫司联合小剂量激素治疗儿童激素抵抗型肾病综合征(NS)的疗效。方法 76例激素抵抗型N S患儿按入院先后顺序分为对照组与观察组各3 8例。两组均给予基础性治疗,观察组加他克莫司与小剂量激素联合治疗,对照组仅加他克莫司。结果血肌酐、血糖水平无论是两组间还是自身前后比较变化均不大,差异无统计学意义。治疗后观察组尿蛋白、三酰甘油低于对照组,白蛋白高于对照组;两组白蛋白较治疗前均有明显升高,24h尿蛋白定量、三酰甘油、胆固醇有明显下降,差异均有统计学意义。观察组缓解率高于对照组,复发率低于对照组,差异有统计学意义。结论对于肾病综合征患儿,虽然出现激素抵抗,但长时间小剂量的激素维持仍可获益。
作者 徐初珍
出处 《中国乡村医药》 2014年第5期3-4,共2页
  • 相关文献

参考文献8

二级参考文献83

  • 1李涛,涂明利,张庆红,费沛,张建鄂.肾病综合征地塞米松冲击治疗新用法探讨[J].临床内科杂志,2002,19(S1):85-87. 被引量:2
  • 2孙嫱,沈颖.Meta分析评价环磷酰胺对儿童肾病综合征的治疗作用[J].中华儿科杂志,2006,44(3):199-201. 被引量:21
  • 3莫樱,陈述枚.肾病综合征频复发及激素依赖的治疗[J].中国实用儿科杂志,2007,22(6):412-416. 被引量:12
  • 4Filler G, Young E, Geier P, et al. Is there really an increase in non-minimal change nephrotic syndrome in children? Am J Kidney Dis ,2003,42 : 1107-1113. 被引量:1
  • 5Eddy AA,Symons JM. Nephrotic syndrome in childhood. Lancet, 2003.362:629-639. 被引量:1
  • 6Wong W. Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study. J Pedia Child Health,2007,43:337-341. 被引量:1
  • 7易著文.小儿临床肾脏病学//易著文,钟巧.肾病综合征.北京:人民卫生出版社,1998:346-361. 被引量:1
  • 8Koskinies O, Vilska J, Rapola J, et al. Long-term outcome of primary nephrotic syndrome. Arch Dis Child, 1987,57:544-548. 被引量:1
  • 9Tarshish P, Tobin JN, Bwenstein J,et al. Prognostic significance of the early course of minimal change nephrotic syndrome:report of the International Study of Kidney Disease in Children. J Am Soc Nephrol, 1997,8:769-779. 被引量:1
  • 10American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Eur Heart J ,2003,24 : 1965-1991. 被引量:1

共引文献403

同被引文献29

  • 1关欣,郑红光.霍平,等.他克莫司对难治性肾病综合征患者临球肾炎[J].肾脏病与透析肾移植杂志,2012,21(3):260-267. 被引量:1
  • 2李世军.改善全球肾脏病预后组织(KDIGO)临床实践指南:肾床疗效的影响[J].贵阳医学院学报,2012,37(5):535-537. 被引量:1
  • 3Hodson EM, WillisoNS, Craig JC. Interventions for idiopathic ste mid-resistant nephrotie syndrome in children. Cochrane Database Systematic Reviews, 2010, Issue 11 : 1-89. 被引量:1
  • 4Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA Statement for'Reporting Systematic Reviews and Meta- Analyses of Studies That Evaluate Health Care Interventions : Expla nation and Elaboration[J]. Annals of Internal Medicine, 2009, 151 (4) :65-94. 被引量:1
  • 5Hartling L, Ospina M, Liang Y, et al. Risk of bias versus quality assessment of randomised controlled trials[J] : cross sectional study. BMJ, 2009, 339:h4012. 被引量:1
  • 6Schulz KF, Altman DG, Moher D; CONSORT Grp. CONSORT 2010 Statement : [J]update guidelines for reporting parallel group randomised trials. Trials, 2010, 11 : 32. 被引量:1
  • 7Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analys ing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Inter y~entions Version 5.0.0 (updated February 2008). [J]The Cochrane Collaboration, 2008. Available from: http://www. Cochrane-hand. 被引量:1
  • 8Gulati A, Sinha A, Gupta A, et al. Treatment with taerolimus and prednisolone is preferable to intravenous eyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome[J]. Kidney International, 2012, 82(10) : 1130-1135. 被引量:1
  • 9Swati C, Arvind B, Pankaj H, et al. Efficacy and safety of Tacroli mus versus Cyclosporine in children with steroid-resistant nephrot ic syndrome: A randomized controlled trial[J].American Journal of Kidney Diseases, 2009, 53(5):760-769. 被引量:1
  • 10Wang WJ, Xia YH, Mao JH, et al. Treatment of tacrolimus or cy closporine A in children with idiopathic nephrotic syndrome[J]. Pe diatric Nephrology, 2012, 27( 11 ) : 2073-2079. 被引量:1

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部